Connect Biopharma Holdings Limited

Contributing Author

Recent Articles by Connect Biopharma Holdings Limited

Jun-13	Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress CNTB GlobeNewswire
Jun-03	Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress CNTB GlobeNewswire
May-28	Connect Biopharma to Present at Two Upcoming Investor Conferences in June CNTB GlobeNewswire
May-20	Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference CNTB GlobeNewswire
May-15	Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update CNTB GlobeNewswire
May-14	Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD CNTB GlobeNewswire
May-13	Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma CNTB GlobeNewswire